Lymphoma
John Theurer Cancer Center is New Jersey’s largest and most specialized lymphoma program. Hundreds of people come to us every year for advanced care based on the latest science, and opportunities to participate in clinical trials of promising new therapies.Our team of expert doctors, nurses and cancer specialists offers the region’s most advanced medical and technological expertise, all while preserving a patient-centric environment that’s focused on treating you, not just your cancer.
Lymphoma is cancer of the lymphatic system – your body's immune defense against infection and cancer. There are many types of lymphoma, including more than 100 subtypes, which fall into two main categories:
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
Many lymphomas look the same under a microscope, but each responds to treatment in a different way. We conduct a molecular analysis of your cancer. This means you receive a highly accurate diagnosis and a treatment plan targeted to your specific type of lymphoma.
The symptoms of lymphoma are the same as for many illnesses. You should make an appointment to see a doctor if you have one or more of the following symptoms. These may be a sign of lymphoma, or another health condition.
- Fever that doesn’t go away
- Itchy skin
- Night sweats
- Painless, swollen lymph nodes in your neck, armpits or groin area not related to a bacteria or viral infection
- Unexplained, persistent lack of energy
- Unexplained weight loss
Lymphoma Clinical Trials and Research
You benefit from John Theurer Cancer Center’s robust research that is advancing the science of lymphoma treatment. Our dedicated research team allows for the full integration of clinical science and trials into our program, giving you access to the newest treatment options available.
We have a clinical research group entirely focused on lymphoma and chronic lymphocytic leukemia (CLL).
Researchers and physicians at the Hackensack Meridian Center for Discovery and Innovation partner with industry leaders on novel, life-changing therapeutic options. Learn More.
As part of the Georgetown Lombardi Comprehensive Cancer Center – a National Cancer Institute-designated comprehensive cancer center – our team offers some of the nation’s most promising Phase I, II and III clinical trials. Learn More.
Our Phase I clinical trial program is the largest in New Jersey, giving you access to new, innovative therapies not available elsewhere.
We are the only center conducting a clinical trial of combined checkpoint inhibitor immunotherapy after stem cell transplant for lymphoma. This has shown promise in improving outcomes and reducing the risk of cancer returning.
